| Date Initiated by Firm | September 13, 2024 |
| Date Posted | October 29, 2024 |
| Recall Status1 |
Open3, Classified |
| Recall Number | Z-0258-2025 |
| Recall Event ID |
95429 |
| Product Classification |
Radioimmunoassay, 17-hydroxyprogesterone - Product Code JLX
|
| Product | 17-OH Progesterone ELISA 96 well kit- An enzyme immunoassay for the quantitative in vitro diagnostic measurement of 17-OH Progesterone (17-OHP) in serum or plasma
Model/Catalog Number: EIA-1292 |
| Code Information |
Lot Code: 04048474012927 (DRG Instruments GmbH)
lots: 22K024 and 22K034
|
| FEI Number |
2245285
|
Recalling Firm/ Manufacturer |
DRG International, Inc. 841 Mountain Ave Springfield NJ 07081-3437
|
| For Additional Information Contact | SAME 862-227-2316 |
Manufacturer Reason for Recall | The High and Low Control acceptance ranges in the Certificate of Analysis (CofA) did not match the acceptance range information on the High and Low Control Component labels. Due to the defect, the device failed to provide results, which may result in a delay in obtaining test results and a remote chance of an adverse health risk.
|
FDA Determined Cause 2 | Process change control |
| Action | DRG issued Urgent Field Safety Notification on 9/17/24 via email. Letter states reason for recall, health risk and action to take:
Please check your inventory for the respective lot and ensure that the proper acceptance ranges provided below are used to validate the assay.
Immediately reply to email: qa@drg-international.com to confirm this notice and your compliance. |
| Quantity in Commerce | 504 units |
| Distribution | AZ, CA, NH
Foreign:
Austria
Belgium
Georgia
Germany
Greece
India
Irak
Italy
Netherlands
Poland
Romania
Russia
Singapore
Spain
Tunesia
Vietnam
|
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|